Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Usefulness of a Virtual Response Test as a Predictor of Functional and Cognitive Abilities in Older Adults With Different Degrees of Cognitive Impairment: a Pilot Study (ReactVR) (ReactVR)

26 maggio 2026 aggiornato da: Pablo Campo-Prieto, University of Vigo
  1. BACKGROUND Population aging is one of the most significant trends of the 21st century.In 2020, 21% of the European population was 65 years of age or older, compared to 16% in 2001.Today, 1 in 9 people is over 60, but it is estimated that by 2050, this will be 1 in 5. Therefore, population aging is a phenomenon that can no longer be ignored. In recent decades, the increase in the number of older people is due to the increase in life expectancy. By 2026, the average life expectancy for men is estimated at 77.65 years, and for women, values are projected to reach 85.5 years.

    Aging is generally associated with neuromuscular deterioration (such as sarcopenia), gait and balance disorders and loss of mobility. In general, a loss of functional independence. In the population over 60 years of age, approximately 3% of muscle strength is lost per year due to muscle denervation and the conversion of type II muscle fibers to type I muscle fibers, decreasing their muscle power for performing activities of daily living. This muscle weakness eventually leads to frailty in older adults, and, consequently, an increased rate of falls and fractures.

    Cognitive ability is also closely related to motor ability, since there are cognitive requirements for developing all physical functions and balance, and these can be altered when attention is diverted or reduced. Executive function and processing speed are some of the cognitive functions related to postural stability, which can be impaired in older adults with cognitive decline. Cognitive decline and dementia are geriatric syndromes with a fairly high incidence. Around 7% of those over 65 years of age are affected. affected, a percentage that increases to 50% for people over 80 years old, which means that more than 1.5 million people in Spain directly suffer from this condition.

    Furthermore, the risk of falls is linked to reaction times, which involve both cognitive and motor aspects (discussed above). These combine attention, perception, and information integration with the final motor response, as well as psychological and emotional factors such as fear of falling or insecurity. Currently, one in three adults over 65 and one in two adults over 80 fall each year, making it a serious public health problem among older adults, as falls lead to premature mortality, loss of independence, and admission to assisted living facilities.

    A widely used scale for predicting the risk of falls is the Time Up and Go (TUG) test. The patient is asked to stand up from a seated position, walk three meters, turn around, and return to the starting position while the time is measured. Patients who do not complete the test in less than 13.5 seconds are considered to have a high risk of falls. Although it is included in various clinical guidelines, the literature recommends identifying alternative tools that can more accurately identify patients at risk of falls, as several studies have shown that the accuracy of this test is limited. Within the TUG (Trauma Glide Test), we have the cognitive TUG (TUG-cog), which assesses the previous test but with the interference of a concurrent cognitive activity. In neurological processes, such as Alzheimer's disease, deficits in divided attention and the ability to perform dual tasks appear to be related to functional mobility impairments, directly linked to the risk of falls.

    Currently, there are also simple reaction time tests (SRTT), which consist of a computerized test to measure a person's reaction times by pressing a response button with the index finger of their dominant hand. However, there is controversy regarding the influence of motor disability on performance in the computerized SRTT task assessment, since the response depends on the ability to press a key with a finger.

    The use of virtual reality software could facilitate the measurement of reaction times in performing functional tasks-tasks that require greater upper limb mobility, which can be a key factor in preventing falls-without being limited to measuring the movement of a single finger.

  2. HYPOTHESES AND OBJECTIVES H0: Knowing the functional reaction times assessed with virtual reality does not help to understand the integrity of the physical, functional, and cognitive abilities of older adults with cognitive impairment, nor can it predict their risk of falling or their level of cognitive impairment.

1) General Objective 1.1 To determine the feasibility of using a virtual reaction time test (VRTT) as a predictor of falls and the level of cognitive impairment in older adults with cognitive impairment.

2) Specific Objectives 2.1 To analyze the relationship between the VRTT and the risk of falling as measured by the Timed Up and Go (TUG) Test. 2.2 Analyze the relationship between VRTT obtained in the virtual test and the level of cognitive impairment measured with the Cambridge Cognitive Examination (CAMCOG). 2.3 Estimate TUG and CAMCOG scores based on reaction times obtained in the VRTT

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Effettivo)

20

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Pontevedra
      • Vigo, Pontevedra, Spagna, 36316
        • University of Vigo

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • age ≥65 years
  • membership in a patient association with cognitive impairment
  • signed informed consent

Exclusion Criteria:

  • cardiovascular, pulmonary or musculoskeletal pathology that limits the evaluation
  • inability to understand instructions
  • severe sensory impairment, vertigo, epilepsy or uncontrolled psychosis

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Virtual reaction time test Group
The intervention will consist of a single session measuring virtual reaction times using Rezill software
A measurement is taken using the Rezzil reaction time test (measured in milliseconds). This software comprises a collection of training games designed to improve physical and cognitive performance across a wide range of sports within an immersive virtual reality environment. In microwall mode, a 3x3 grid is presented, and the objective is to respond to a random stimulus projected onto it with a rapid limb movement, making several attempts over 45 seconds.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Virtual reality reaction time test
Lasso di tempo: Baseline

A measurement is taken using the Rezzil reaction time test (measured in milliseconds). This software comprises a collection of training games designed to improve physical and cognitive performance across a wide range of sports within an immersive virtual reality (VR) environment. In microwall mode, a 3x3 grid is presented, and the objective is to respond to a random stimulus projected onto it with a rapid limb movement, making several attempts over 45 seconds.

The average reaction time is recorded

Baseline

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Level of cognitive impairment assessed using the Global Deterioration Scale (GDS)
Lasso di tempo: Baseline

GDS is is a 7-stage clinical assessment tool used to measure the progression of cognitive decline and dementia. The scale breaks down cognitive health into the following stages:

Stage 1: No Cognitive Decline. Stage 2: Very Mild Cognitive Decline. Stage 3: Mild Cognitive Decline. Stage 4: Moderate Cognitive Decline. Considered early dementia. Stage 5: Moderately Severe Cognitive Decline. Middle dementia stage. Stage 6: Severe Cognitive Decline. Dementia Stage 7: Very Severe Cognitive Decline. Late-stage dementia.

Baseline
Level of cognitive ability assessed using the Cambridge Cognitive Examination-Revised (CAMCOG-R) test
Lasso di tempo: Baseline

The CAMCOG-R is a comprehensive neuropsychological test designed to evaluate cognitive impairment and assist in diagnosing dementia. Total score ranges from 0 to 105 points, with higher scores indicating better cognitive function.

The CAMCOG-R thoroughly evaluates 8 core neurological and cognitive domains:Orientation (10 points): Measures awareness of time, date, and location.Language (30 points): Tests comprehension, naming, reading, writing, and verbal fluency.Memory (27 points): Assesses remote memory, recent memory, and learning ability (including delayed recall).Attention and Calculation (9 points): Evaluates working memory and arithmetic skills.Praxis (12 points): Tests motor planning through tasks like copying shapes or mimicking actions (e.g., folding paper).Abstraction (8 points): Measures problem-solving and the ability to understand similarities.Perception (9 points): Assesses visual perception and spatial recognition.Executive Function: Evaluates higher-order organization

Baseline
Gait functionality measured with the Timed Up and Go Test (TUG test)
Lasso di tempo: Baseline

The TUG test is a quick, functional assessment used by physical therapists and healthcare providers to measure a person's mobility, balance, and fall risk. The test records how long it takes to stand from a chair, walk 3 meters, turn, and sit back down. Results are evaluated based on the time taken to complete the task:

<10 Seconds: Normal, independent mobility. 10 to 12 Seconds: Indicates a moderate risk of falling. 12 to 14 Seconds: Indicates a high risk of falling. >20 Seconds: Poor functional mobility; often requires further assessment for outside mobility and assistive devices.

>30 Seconds: Indicates significant mobility impairment and dependency.

Baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

25 maggio 2026

Completamento primario (Effettivo)

25 maggio 2026

Completamento dello studio (Effettivo)

26 maggio 2026

Date di iscrizione allo studio

Primo inviato

26 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

26 maggio 2026

Primo Inserito (Effettivo)

2 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

26 maggio 2026

Ultimo verificato

1 aprile 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • HEALTHYFIT-UVIGO 2/2026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Virtual reality reaction time test

Sottoscrivi